Correction: Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization

Correction: Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization

Show other versions (1)

Bibliographic Details
Main Authors:	Christina L. Grant, Leslie A. Caromile, Khayyam Durrani, M. Mamunur Rahman, Kevin P. Claffey, Guo-Hua Fong, Linda H. Shapiro
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552747/?tool=EBI

Similar Items

Correction: Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization.
by: Christina L. Grant, et al.
Published: (2012-01-01)

Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization.
by: Christina L Grant, et al.
Published: (2012-01-01)

Correlation Between PSMA and VEGF Expression as Markers for LNCaP Tumor Angiogenesis
by: Paulus Tsui, et al.
Published: (2005-01-01)

Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
by: Xiaochuan Huo, et al.
Published: (2015-03-01)

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01)

Effects of anti-vegf agents on the ocular neovascular structures in diabetic retinopathyes
by: Manuela Beruica
Published: (2009-06-01)

Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis.
by: Mien V Hoang, et al.
Published: (2010-10-01)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)

Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway
by: Hannah Murray, et al.
Published: (2021-09-01)

Angiogenesis and vasculogenesis for therapeutic neovascularization
by: Murohara, Toyoaki
Published: (2003)

Recent advances in ocular drug delivery systems and targeting VEGF receptors for management of ocular angiogenesis: A comprehensive review
by: Soumya Narayana, et al.
Published: (2021-09-01)

Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions.
by: Xiao Dong, et al.
Published: (2011-04-01)

Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology
by: María L. Formica, et al.
Published: (2021-04-01)

Lipid Signaling in Ocular Neovascularization
by: Ryo Terao, et al.
Published: (2020-07-01)

LncRNAs in ocular neovascularizations
by: Yacouba Cissé, et al.
Published: (2019-12-01)

Anti-VEGF medicine with PRP for neovascular glaucoma
by: Yue Deng, et al.
Published: (2018-10-01)

Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
Published: (2020)

Nuclear factor kappa-B signaling is integral to ocular neovascularization in ischemia-independent microenvironment.
by: Michael DeNiro, et al.
Published: (2014-01-01)

Ocular Angiogenesis
by: Juliana L. Dreyfuss, et al.
Published: (2015-01-01)

Application of anti-VEGF agents on the treatment of neovascular glaucoma
by: Qi-Meng Chu, et al.
Published: (2016-01-01)

Safety of anti-VEGF drugs with trabeculectomy for neovascular glaucoma
by: Fei Wang, et al.
Published: (2016-05-01)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
by: Praveen Yerramothu
Published: (2018-07-01)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
by: Deli Krizova, et al.
Published: (2014-01-01)

Research on soluble VEGF receptor 1 in retinal neovascularization
by: Xiao-Yuan Cui, et al.
Published: (2018-03-01)

A review on vasohibin and ocular neovascularization
by: Xiao-Nan Hu, et al.
Published: (2020-06-01)

Omics Technologies and Neovascular Ocular Disorders
by: Daniel Petrovič, et al.
Published: (2014-01-01)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
by: César López-Camarillo, et al.
Published: (2020-07-01)

Angiogenesis: A special reference to corneal neovascularization
by: Nikolić Ljubiša, et al.
Published: (2015-01-01)

Retraction: Nuclear factor kappa-B signaling is integral to ocular neovascularization in ischemia-independent microenvironment.
by: PLOS ONE Editors
Published: (2019-01-01)

Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway
by: Yang Gao, et al.
Published: (2021-03-01)

Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade
by: Diana V. Do, et al.
Published: (2012-11-01)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
by: Greggory M. Gahn, et al.
Published: (2018-03-01)

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
by: Marie Christine Hupe, et al.
Published: (2018-12-01)

Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis
by: A. Salvadori, et al.
Published: (2018-01-01)

Angiogenesis: bFGF and VEGF in breast carcinoma
by: Vujasinović Tijana, et al.
Published: (2006-01-01)

Evaluation Of VEGF Peptide Mimics As Inhibitors Of Angiogenesis
by: Vicari, Daniele
Published: (2008)

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy
by: Maxim Rybalov, et al.
Published: (2014-04-01)

Gene therapy for ocular angiogenesis
by: Bainbridge, James William Braithwaite
Published: (2003)

CRISPR Technology for Ocular Angiogenesis
by: Sook Hyun Chung, et al.
Published: (2020-12-01)

Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it
by: Jian-Bo Mao, et al.
Published: (2021-08-01)